US Stock MarketDetailed Quotes

NKGN NKGEN BIOTECH

Watchlist
  • 1.440
  • -0.120-7.69%
Close Jun 4 16:00 ET
35.84MMarket Cap-379P/E (TTM)

NKGEN BIOTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.91%-4.03M
2.70%-21.95M
-26.95%-6.94M
-4.91M
-15.39%-22.56M
-5.47M
-19.55M
Net income from continuing operations
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
---8.32M
-15.00%-26.75M
---6.95M
---23.27M
Operating gains losses
---4.53M
--48.2M
--23.73M
----
----
----
----
Depreciation and amortization
7.24%326K
-0.58%1.2M
-1.96%300K
--304K
-2.73%1.21M
--306K
--1.24M
Other non cash items
32.27%2.16M
54.74%4.2M
-59.14%293K
--1.63M
107.74%2.71M
--717K
--1.31M
Change In working capital
953.24%2.28M
7,320.00%2.23M
299.15%1.42M
--216K
-96.78%30K
--355K
--932K
-Change in receivables
--0
200.00%29K
--0
--29K
-126.13%-29K
--16K
--111K
-Change in prepaid assets
340.88%330K
-2,561.40%-1.4M
-451.92%-366K
---137K
218.75%57K
--104K
---48K
-Change in payables and accrued expense
325.00%1.85M
801.35%3.99M
437.78%1.89M
--436K
-53.81%443K
--352K
--959K
-Change in other current liabilities
193.94%93K
13.27%-379K
12.73%-96K
---99K
-276.72%-437K
---110K
---116K
-Change in other working capital
92.31%-1K
-250.00%-14K
----
---13K
-115.38%-4K
---7K
--26K
Cash from discontinued investing activities
Operating cash flow
17.91%-4.03M
2.70%-21.95M
-26.95%-6.94M
---4.91M
-15.39%-22.56M
---5.47M
---19.55M
Investing cash flow
Cash flow from continuing investing activities
369.23%35K
70.55%-48K
-260.00%-18K
-13K
64.49%-163K
-5K
-459K
Capital expenditure reported
--0
22.58%-48K
-38.46%-18K
---13K
-10.71%-62K
---13K
---56K
Net PPE purchase and sale
--35K
--0
--0
--0
74.94%-101K
--8K
---403K
Cash from discontinued investing activities
Investing cash flow
369.23%35K
70.55%-48K
-260.00%-18K
---13K
64.49%-163K
---5K
---459K
Financing cash flow
Cash flow from continuing financing activities
-27.91%4.01M
-1.47%22.16M
-132.78%-1.8M
5.56M
11.54%22.49M
5.5M
20.16M
Net issuance payments of debt
-73.46%1.47M
17.38%26.21M
-104.36%-240K
--5.55M
11.09%22.33M
--5.5M
--20.1M
Net common stock issuance
----
--1.67M
--1K
----
--0
--0
----
Proceeds from stock option exercised by employees
6,150.00%250K
6,249.07%10.22M
--0
--4K
155.56%161K
--1K
--63K
Net other financing activities
--2.28M
---15.94M
---1.56M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-27.91%4.01M
-1.47%22.16M
-132.78%-1.8M
--5.56M
11.54%22.49M
--5.5M
--20.16M
Net cash flow
Beginning cash position
135.90%276K
-66.67%117K
10,286.21%9.04M
--117K
76.38%351K
--87K
--199K
Current changes in cash
-98.73%8K
167.95%159K
-29,300.00%-8.76M
--631K
-253.95%-234K
--30K
--152K
End cash Position
-62.03%284K
135.90%276K
135.90%276K
--748K
-66.67%117K
--117K
--351K
Free cash flow
18.12%-4.03M
3.19%-22M
-27.16%-6.96M
---4.93M
-13.56%-22.72M
---5.47M
---20.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.91%-4.03M2.70%-21.95M-26.95%-6.94M-4.91M-15.39%-22.56M-5.47M-19.55M
Net income from continuing operations 35.33%-5.38M-210.06%-82.95M-383.68%-33.61M---8.32M-15.00%-26.75M---6.95M---23.27M
Operating gains losses ---4.53M--48.2M--23.73M----------------
Depreciation and amortization 7.24%326K-0.58%1.2M-1.96%300K--304K-2.73%1.21M--306K--1.24M
Other non cash items 32.27%2.16M54.74%4.2M-59.14%293K--1.63M107.74%2.71M--717K--1.31M
Change In working capital 953.24%2.28M7,320.00%2.23M299.15%1.42M--216K-96.78%30K--355K--932K
-Change in receivables --0200.00%29K--0--29K-126.13%-29K--16K--111K
-Change in prepaid assets 340.88%330K-2,561.40%-1.4M-451.92%-366K---137K218.75%57K--104K---48K
-Change in payables and accrued expense 325.00%1.85M801.35%3.99M437.78%1.89M--436K-53.81%443K--352K--959K
-Change in other current liabilities 193.94%93K13.27%-379K12.73%-96K---99K-276.72%-437K---110K---116K
-Change in other working capital 92.31%-1K-250.00%-14K-------13K-115.38%-4K---7K--26K
Cash from discontinued investing activities
Operating cash flow 17.91%-4.03M2.70%-21.95M-26.95%-6.94M---4.91M-15.39%-22.56M---5.47M---19.55M
Investing cash flow
Cash flow from continuing investing activities 369.23%35K70.55%-48K-260.00%-18K-13K64.49%-163K-5K-459K
Capital expenditure reported --022.58%-48K-38.46%-18K---13K-10.71%-62K---13K---56K
Net PPE purchase and sale --35K--0--0--074.94%-101K--8K---403K
Cash from discontinued investing activities
Investing cash flow 369.23%35K70.55%-48K-260.00%-18K---13K64.49%-163K---5K---459K
Financing cash flow
Cash flow from continuing financing activities -27.91%4.01M-1.47%22.16M-132.78%-1.8M5.56M11.54%22.49M5.5M20.16M
Net issuance payments of debt -73.46%1.47M17.38%26.21M-104.36%-240K--5.55M11.09%22.33M--5.5M--20.1M
Net common stock issuance ------1.67M--1K------0--0----
Proceeds from stock option exercised by employees 6,150.00%250K6,249.07%10.22M--0--4K155.56%161K--1K--63K
Net other financing activities --2.28M---15.94M---1.56M----------------
Cash from discontinued financing activities
Financing cash flow -27.91%4.01M-1.47%22.16M-132.78%-1.8M--5.56M11.54%22.49M--5.5M--20.16M
Net cash flow
Beginning cash position 135.90%276K-66.67%117K10,286.21%9.04M--117K76.38%351K--87K--199K
Current changes in cash -98.73%8K167.95%159K-29,300.00%-8.76M--631K-253.95%-234K--30K--152K
End cash Position -62.03%284K135.90%276K135.90%276K--748K-66.67%117K--117K--351K
Free cash flow 18.12%-4.03M3.19%-22M-27.16%-6.96M---4.93M-13.56%-22.72M---5.47M---20.01M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg